| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 08/27/2009 | US20090216336 Bioresorbable, mineralised material for filling osseous defects |
| 08/27/2009 | US20090215988 Soluble, Degradable Poly(Ethylene Glycol) Derivatives for Controllable Release of Bound Molecules into Solution |
| 08/27/2009 | US20090215910 Method for the Preparation of 1-Benzotriazolyl Carbonate Esters of Poly(Ethylene Glycol) |
| 08/27/2009 | US20090215890 Gamma-hydroxybutyrate compositions containing carbohydrate, lipid or amino acid carriers |
| 08/27/2009 | US20090215808 Oral pharmaceutical dosage forms |
| 08/27/2009 | US20090215739 Chemical method of making a suspension, emulsion or dispersion of pyrithione particles |
| 08/27/2009 | US20090215167 Cationic graft-copolymer for non-viral gene delivery vector |
| 08/27/2009 | US20090215089 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin |
| 08/27/2009 | US20090214670 Rhcc peptide and uses thereof |
| 08/27/2009 | US20090214666 Chitin microparticles and their medical uses |
| 08/27/2009 | US20090214640 Delayed release pharmaceutical oral dosage form and method of making same |
| 08/27/2009 | US20090214620 Agent for use in the case of disorders of blood sugar metabolism, including diabetes |
| 08/27/2009 | US20090214617 Immobilisation and stabilisation of virus |
| 08/27/2009 | US20090214605 Hydrophilic Core Polymeric Micelles for the Delivery of Water-Soluble Compounds |
| 08/27/2009 | US20090214601 Porous Drug Delivery Devices and Related Methods |
| 08/27/2009 | US20090214599 Proton pump inhibitor formulations, and methods of preparing and using such formulations |
| 08/27/2009 | US20090214574 Anti-cd16 binding molecules |
| 08/27/2009 | US20090214505 For treating an excess of a substrate for a hyaluronidase, such as reducing scar tissue |
| 08/27/2009 | US20090214470 Eye-drop vaccine containing copolymer 1 for therapeutic immunization |
| 08/27/2009 | US20090214422 DNA encoding a novel RG1 polypeptide |
| 08/27/2009 | DE202008017456U1 Flüssig-Formulierung von G-CSF-Konjugaten Liquid formulation of G-CSF Conjugates |
| 08/27/2009 | DE202008017304U1 Oral zerfallender Film zur therapeutischen Anwendung von Antiparasitika bei Tieren Oral disintegrating film for the therapeutic use of antiparasitic agents in animals |
| 08/27/2009 | DE202008005278U1 Hautschutzzusammensetzung Skin-protective composition |
| 08/27/2009 | DE102008009646A1 Drug carrier system, useful e.g. for placement through urethra to bladder, comprises active ingredient and carrier material, where carrier material is able to release ingredient on long-term basis within the bladder |
| 08/27/2009 | CA2750762A1 Treatment of neural diseases or conditions |
| 08/27/2009 | CA2716185A1 Compositions and methods for treating ophthalmic diseases |
| 08/27/2009 | CA2715760A1 Solid preparation for oral administration |
| 08/27/2009 | CA2715665A1 Microparticle and pharmaceutical composition thereof |
| 08/27/2009 | CA2715626A1 Sustained release poloxamer containing pharmaceutical compositions |
| 08/26/2009 | EP2093248A1 Method for removing organic solvent |
| 08/26/2009 | EP2092936A2 Tamper-resistant oral opioid agonist formulations |
| 08/26/2009 | EP2092935A1 Pharmaceutical compositions for the treatment of asthma |
| 08/26/2009 | EP2092069A2 Modified soluble fgf receptor fc fusions with improved biological activity |
| 08/26/2009 | EP2092058A1 Cancerous disease modifying antibodies |
| 08/26/2009 | EP2091569A2 Targeted delivery of therapeutic agents with lyophilized matrices |
| 08/26/2009 | EP2091568A2 Fusion proteins comprising a anti-inflammatory cytokine and an antigen for treatment of immune disorders |
| 08/26/2009 | EP2091567A2 Dissolution and processing of cellulose |
| 08/26/2009 | EP2091543A1 Complex formulation for preventing or treating osteoporosis which comprises solid dispersion of vitamin d or its derivative and bisphosphonate |
| 08/26/2009 | EP2091518A1 Method for mixing powders |
| 08/26/2009 | EP2091514A2 Water insoluble polymer matrix for drug delivery |
| 08/26/2009 | EP2091513A2 Ejection liquid and ejection method |
| 08/26/2009 | EP1648518B1 Conjugated biological molecules and their preparation |
| 08/26/2009 | EP1624891B1 Clotting factor-fc chimeric proteins to treat hemophilia |
| 08/26/2009 | EP1568283B1 Method of inhibiting acrylamide formation and use thereof |
| 08/26/2009 | EP1536840B1 Formulation for inwardly transferring nucleic acids into eucaryotic cells |
| 08/26/2009 | EP1478328A4 Bioactive keratin peptides |
| 08/26/2009 | EP1450855B1 Suppression of allergic reactions by transdermal administration of allergens in conjunction with or conjugated to toxin subunits or fragments thereof |
| 08/26/2009 | EP1389096B9 Delivery of opioids through an inhalation route |
| 08/26/2009 | EP1389089B1 Method and composition for solubilising a biologically active compound with low water solubility |
| 08/26/2009 | EP1368057B1 Method to enhance the immunogenicity of an antigen |
| 08/26/2009 | EP1345587B1 Ionophore antibiotic formulations |
| 08/26/2009 | EP1330266B2 Method for making very fine particles consisting of a principle inserted in a host molecule |
| 08/26/2009 | EP1283218B1 Compound comprising crosslinked polyrotaxane |
| 08/26/2009 | EP1237915B1 Polynucleotid encoding the rg1 polypeptide |
| 08/26/2009 | EP1061812B1 Food products having enhanced cocoa polyphenol content and processes for producing same |
| 08/26/2009 | EP1012187B1 Chemokine peptides, variants, derivatives and analogs. their use in methods to inhibit or augment an inflammatory response |
| 08/26/2009 | CN101516404A Camptothecin-peptide conjugates and pharmaceutical compositions containing the same |
| 08/26/2009 | CN101516403A Orally disintegrating tablet and process for production thereof |
| 08/26/2009 | CN101516402A Gel type enteric nutrient |
| 08/26/2009 | CN101516367A Solid pharmaceutical composition for optically stable ramosetron |
| 08/26/2009 | CN101516358A Antiviral compositions and use thereof |
| 08/26/2009 | CN101516349A Pharmaceutical compositions containing rosuvastatin calcium |
| 08/26/2009 | CN101516348A Solid preparation comprising ibuprofen and tranexamic acid |
| 08/26/2009 | CN101516334A Stabilizing compositions for antibiotics and methods of use |
| 08/26/2009 | CN101516332A Self preserved aqueous pharmaceutical compositions |
| 08/26/2009 | CN101516331A Edible water-soluble film containing a foam reducing flavoring agent |
| 08/26/2009 | CN101514232A RANKL-Fc fusion protein, preparation method and application thereof |
| 08/26/2009 | CN101514229A Human interferon alpha derivative and polyethylene glycol modified substance thereof |
| 08/26/2009 | CN101514223A Method for preparation of site-specific protein conjugates |
| 08/26/2009 | CN101514189A Glycin diazole tromethamine compound as well as preparation method and medicament application thereof |
| 08/26/2009 | CN101513531A Soft capsule matrix and preparation method thereof |
| 08/26/2009 | CN101513530A Polyhydroxyalkanoate (PHA) targeted carrier, drug-loading nano-particle and preparation methods and application thereof |
| 08/26/2009 | CN101513529A W/O type micro emulsion carrier for insulin injection and preparation method thereof |
| 08/26/2009 | CN101513526A Application of combined vaccine in treating tumors |
| 08/26/2009 | CN101513525A Application of collagen and pharmaceutical compositions thereof in gynecology |
| 08/26/2009 | CN101513524A Alpha-interferon dry powder inhalant for pigs and method for producing same |
| 08/26/2009 | CN101513523A Medicine containing cell polypeptide growth factor and preparation method thereof |
| 08/26/2009 | CN101513454A Laxative composition with improved drug delivery system |
| 08/26/2009 | CN101513452A Decumbent corydalis tuber cataplasm and preparation method thereof |
| 08/26/2009 | CN101513439A Notoginseng sodium hyaluronate gel for preventing from adhesion after spine laminectomy |
| 08/26/2009 | CN101513431A Omphalia preparation and preparation method |
| 08/26/2009 | CN101513428A Preparation for preventing livestock locoweed poisoning |
| 08/26/2009 | CN101513409A Pharmaceutical composition of cephalexin |
| 08/26/2009 | CN101513405A Use of chemotherapeutic agents |
| 08/26/2009 | CN101513403A Pharmaceutical preparation containing benzimidazoles |
| 08/26/2009 | CN101513400A Ampelopsin and basic amino acid solubilizing system |
| 08/26/2009 | CN101513397A Anastrozole controlled release patch and preparation method thereof |
| 08/26/2009 | CN101513394A Continuous preparation method for nanometer dispersed vitamin A microcapsule |
| 08/26/2009 | CN101513393A Silymarin soft capsule and method for preparing same |
| 08/26/2009 | CN101513392A Process for preparing slow and controlled micro pills |
| 08/26/2009 | CN101513391A Manufacturing of quick release pharmaceutical compositions of water insoluble drugs and pharmaceutical compositions obtained by the process of the invention |
| 08/26/2009 | CN101513390A Hydrochloric acid boanmycin liposomes and preparation method thereof |
| 08/26/2009 | CN101513389A Oral puerarin nano suspension for improving bioavailability of puerarin |
| 08/26/2009 | CN101513388A Icariin microemulsion and preparation method thereof |
| 08/26/2009 | CN100532436C Water dispersible magnetic polymer microsphere, preparing method and application of the same |
| 08/26/2009 | CN100532392C Reductive alkylation process |
| 08/26/2009 | CN100531889C Process for producing coated fine particle |
| 08/26/2009 | CN100531801C Polyethylene glycol prodrug of gambogicacid, its preparation method, formulation and use for preparing drug |
| 08/26/2009 | CN100531800C Drug delivery system based on polyethylene vinylacetate copolymers |
| 08/26/2009 | CN100531797C Novel use of erythropoietin in heart diseases |